Pien-Tze-Huang attenuates neuroinflammation in cerebral ischaemia-reperfusion injury in rats through the TLR4/NF-κB/MAPK pathway

References

• Bai QK, Zhao ZG, Lu LJ, Shen J, Zhang JY, Sui HJ, Xie XH, Chen J, Yang J, Chen CR. 2019. Treating ischaemic stroke with intravenous tPA beyond 4.5 hours under the guidance of a MRI DWI/T2WI mismatch was safe and effective. Stroke Vasc Neurol. 4(1):8–13.
   PubMedGoogle Scholar
• Benjamin EJ, Virani SS, Callaway CW, Chamberlain AM, Chang AR, Cheng S, Chiuve SE, Cushman M, Delling FN, Deo R, et al. 2018. Heart disease and stroke statistics-2018 update: a report from the American Heart Association. Circulation. 137(12):e67–e492.
   PubMed Web of Science ®Google Scholar
• Berekashvili K, Soomro J, Shen L, Misra V, Chen PR, Blackburn S, Dannenbaum M, Grotta JC, Barreto AD. 2018. Safety and feasibility of argatroban, recombinant tissue plasminogen activator, and intra-arterial therapy in stroke (ARTSS-IA Study). J Stroke Cerebrovasc Dis. 27(12):3647–3651.
   PubMed Web of Science ®Google Scholar
• Beutler BA. 2009. TLRs and innate immunity. Blood. 113(7):1399–1407.
   PubMed Web of Science ®Google Scholar
• Deng Y, Luo H, Shu J, Shu H, Lu C, Zhao N, Geng Y, He X, Lu A. 2020. Pien Tze Huang alleviate the joint inflammation in collagen-induced arthritis mice. Chin Med. 15:30–39.
   PubMed Web of Science ®Google Scholar
• Denlinger CE. 2016. Toll-like receptor 4 inhibition attenuates ischemia-reperfusion injury in rats: will it work in human beings? J Thorac Cardiovasc Surg. 151(2):507–508.
   PubMed Web of Science ®Google Scholar
• Eltzschig HK, Eckle T. 2011. Ischemia and reperfusion-from mechanism to translation. Nat Med. 17(11):1391–1401.
   PubMed Web of Science ®Google Scholar
• Esenwa CC, Elkind MS. 2016. Inflammatory risk factors, biomarkers and associated therapy in ischaemic stroke. Nat Rev Neurol. 12(10):594–604.
   PubMed Web of Science ®Google Scholar
• Gonzalo-Gobernado R, Ayuso MI, Sansone L, Bernal-Jimenez JJ, Ramos-Herrero VD, Sanchez-Garcia E, Ramos TL, Abia R, Muriana FJG, Bermudez B, et al. 2019. Neuroprotective effects of diets containing olive oil and DHA/EPA in a mouse model of cerebral ischemia. Nutrients. 11(5):1109–1126.
   PubMed Web of Science ®Google Scholar
• Hakimizadeh E, Kazemi Arababadi M, Shamsizadeh A, Roohbakhsh A, Allahtavakoli M. 2016. The possible role of toll-like receptor 4 in the pathology of stroke. Neuroimmunomodulation. 23(3):131–136.
   PubMed Web of Science ®Google Scholar
• Hua F, Tang H, Wang J, Prunty MC, Hua X, Sayeed I, Stein DG. 2015. TAK-242, an antagonist for Toll-like receptor 4, protects against acute cerebral ischemia/reperfusion injury in mice. J Cereb Blood Flow Metab. 35(4):536–542.
   PubMed Web of Science ®Google Scholar
• Huang L, Zhang Y, Zhang X, Chen X, Wang Y, Lu J, Huang M. 2019. Therapeutic potential of Pien-Tze-Huang: a review on its chemical composition, pharmacology, and clinical application. Molecules. 24(18):3274–3289.
   PubMed Web of Science ®Google Scholar
• Huang M, Xu W, Zhang Y, Liu J, Zhang X, Lin J, Peng J, Lu J. 2016. Identification and quantification of the anti-inflammatory constituents in Pian-Tze-Huang by liquid chromatography combined with quadrupole time-of-flight and triple quadrupole mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 1027:27–39.
   PubMed Web of Science ®Google Scholar
• Kumar V. 2019. Toll-like receptors in the pathogenesis of neuroinflammation. J Neuroimmunol. 332:16–30.
   PubMed Web of Science ®Google Scholar
• Lavelle EC, Murphy C, O'Neill LA, Creagh EM. 2010. The role of TLRs, NLRs, and RLRs in mucosal innate immunity and homeostasis. Mucosal Immunol. 3(1):17–28.
   PubMed Web of Science ®Google Scholar
• Li WL, Yu SP, Chen D, Yu SS, Jiang YJ, Genetta T, Wei L. 2013. The regulatory role of NF-κB in autophagy-like cell death after focal cerebral ischemia in mice. Neuroscience. 244:16–30.
   PubMed Web of Science ®Google Scholar
• Ling C, Liang J, Zhang C, Li R, Mou Q, Qin J, Li X, Wang J. 2018. Synergistic effects of salvianolic acid B and puerarin on cerebral ischemia reperfusion injury. Molecules. 23(3):564–580.
   PubMed Web of Science ®Google Scholar
• Liu LX, Zhang XM, Zhu LQ, Huang YX, Li Q, Zhou YH. 2014. Effect of Pien Tze Huang on amount of IL-6 and IL-1β of focal cerebral infarction rats. Chinese Arch Trad Chinese Med. 32:515–517.
   Google Scholar
• Longa EZ, Weinstein PR, Carlson S, Cummins R. 1989. Reversible middle cerebral artery occlusion without craniectomy in rats. Stroke. 20(1):84–91.
   PubMed Web of Science ®Google Scholar
• Ostrowski RP, Stępień K, Pucko E, Matyja E. 2016. Hyperbaric oxygen modalities are differentially effective in distinct brain ischemia models. Med Gas Res. 6(1):39–47.
   PubMed Web of Science ®Google Scholar
• Parada E, Casas AI, Palomino-Antolin A, Gómez-Rangel V, Rubio-Navarro A, Farré-Alins V, Narros-Fernandez P, Guerrero-Hue M, Moreno JA, Rosa JM, et al. 2019. Early toll-like receptor 4 blockade reduces ROS and inflammation triggered by microglial pro-inflammatory phenotype in rodent and human brain ischaemia models. Br J Pharmacol. 176(15):2764–2779.
   PubMed Web of Science ®Google Scholar
• Shi K, Tian DC, Li ZG, Ducruet AF, Lawton MT, Shi FD. 2019. Global brain inflammation in stroke. Lancet Neurol. 18(11):1058–1066.
   PubMed Web of Science ®Google Scholar
• Shichita T, Ago T, Kamouchi M, Kitazono T, Yoshimura A, Ooboshi H. 2012. Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J Neurochem. 123(Suppl 2):29–38.
   PubMedGoogle Scholar
• Takaoka A, Yanai H, Kondo S, Duncan G, Negishi H, Mizutani T, Kano S, Honda K, Ohba Y, Mak TW, et al. 2005. Integral role of IRF-5 in the gene induction programme activated by Toll-like receptors. Nature. 434(7030):243–249.
   PubMed Web of Science ®Google Scholar
• Tobin MK, Bonds JA, Minshall RD, Pelligrino DA, Testai FD, Lazarov O. 2014. Neurogenesis and inflammation after ischemic stroke: what is known and where we go from here. J Cereb Blood Flow Metab. 34(10):1573–1584.
   PubMed Web of Science ®Google Scholar
• Tse KH, Chow KB, Leung WK, Wong YH, Wise H. 2014. Lipopolysaccharide differentially modulates expression of cytokines and cyclooxygenases in dorsal root ganglion cells via Toll-like receptor-4 dependent pathways. Neuroscience. 267:241–251.
   PubMed Web of Science ®Google Scholar
• Tuttolomondo A, Di Sciacca R, Di Raimondo D, Renda C, Pinto A, Licata G. 2009. Inflammation as a therapeutic target in acute ischemic stroke treatment. Curr Top Med Chem. 9(14):1240–1260.
   PubMed Web of Science ®Google Scholar
• Zhang L, Lam WP, Lu L, Wang YX, Wong YW, Lam LH, Tang HC, Wai MS, Mak YT, Wang M, et al. 2011. How would composite traditional Chinese medicine protect the brain-an example of the composite formula "Pien Tze Huang". Curr Med Chem. 18(23):3590–3594.
   PubMed Web of Science ®Google Scholar
• Zhang LH, Lam WP, Lü LH, Wang CM, Wong YW, Lam LH, Tang HC, Wai MS, Wang MW, Kwong WH, et al. 2010. Protective effects and potential mechanisms of Pien Tze Huang on cerebral chronic ischemia and hypertensive stroke. Chin Med. 5:35–49.
   PubMedGoogle Scholar
• Zhang X, Fei XJ, Tao WW, Li JB, Shen H, Wang XY, Liu HQ, Xu Y. 2017. Neuroprotective effect of modified Xijiao Dihuang decoction against oxygen-glucose deprivation and reoxygenation-induced injury in PC12 cells: involvement of TLR4-MyD88/NF-κB Signaling Pathway. Evid Based Complement Alternat Med. 2017:3848595–3848511.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang Y, Tang S, Yu L, Zhao Y, Ren Q, Huang X, Xu W, Huang M, Peng J. 2018. Pien-Tze-Huang protects cerebral ischemic injury by inhibiting neuronal apoptosis in acute ischemic stroke rats. J Ethnopharmacol. 219:117–125.
   PubMed Web of Science ®Google Scholar
• Zheng H, Wang X, Zhang Y, Chen L, Hua L, Xu W. 2019. Pien-Tze-Huang ameliorates hepatic fibrosis via suppressing NF-κB pathway and promoting HSC apoptosis. J Ethnopharmacol. 244:111856.
   PubMed Web of Science ®Google Scholar